BMO Capital maintains Outperform on Intercept Pharmaceuticals (NASDAQ: ICPT) price target of $160.00.Analyst Ian Somaiya says physician education appears to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE